-
News Agency News Aggregator Journalist/Editor Broking House Others
#Broker #StockTip: Hold Cipla, target of Rs 1158: Sharekhan
Tata Motors, Bajaj Auto rise 6% each following better-than-expected Q3 earnings Dr Reddy’s & Cipla too see gains following a healthy set of earnings PVR rises more than 5% on a strong Pathaan movie collections
Top Gainers ⏫and Losers⏬ for 27-Jan-23 #AskExpertAtGEPLCapital #stayinvested100 #stockstowatch #stockstobuy #GEPLCapital #TataMotors #bajajauto #DRREDDY #ITC #cipla #Nifty50 #marketcrash
#MarketAtClose | Tata Motors, Bajaj Auto rise 6% each following better-than-expected Q3 earnings Dr Reddy’s & Cipla too see gains following a healthy set of earnings PVR rises more than 5% on a strong Pathaan movie collections
Triggered #CIPLA
Shares of #Cipla gain due to a strong U.S. pipeline and improving margins. #BQStocks
#MarketHeadlines * #Equities slump; Energy & utilities lead the slide * Dr Reddy’s beats Q3 estimates, #Cipla misses expectations * #TataMotors turns profitable after two-year hiatus * SEBI: 9 out of 10 traders lose money in F&O transactions
Top gainers from BSE100 index [Automated 27-Jan 11:55 AM] 6.51% : BAJAJ-AUTO 5.99% : TATAMOTORS 4.94% : TATAMTRDVR 3.03% : DRREDDY 1.96% : CIPLA Data: bseindia
🩺#Formulation में विदेशी फार्मा कंपनियों से घरेलू फार्मा कंपनियों को होगा फायदा ? ⚡️फार्मा सेक्टर: आएंगे अच्छे दिन ? जानिए पूरी डिटेल्स नुपूर से... #Cipla #DrReddy #DivisLab @Nupurkunia देखिए Zee Business LIVE -
Buzzing #Stock: Cipla Q3 profit up 10%, brokerages remain positive
Watch out for short opportunity in #cipla on break and retest of 1045 (spot) #stocks #StockMarket
⚡️#EditorsTake | कौनसे शेयर है आज के Stock of the day? #DixonTech में आज क्या करें? #TataMotors , Dr Reddy's और Cipla के नतीजे कैसे हैं? #PharmaStocks के लिए बुरा वक्त हुआ खत्म?🟢 December तिमाही नतीजों का पूरा विश्लेषण @AnilSinghvi_ से #ResultsOnZee #AnilSinghvi #Stocks
#CNBCTV18Market | Jefferies gives hold rating on Cipla, says Q3 missed revenue/EBITDA est by 6% on revenue decline in SAGA & muted growth in India US was strong on back of seasonality & market share gains in key products
HSBC on Cipla Maintain Buy, Target cut to 1240 from 1350 Macquarie on Cipla Maintain Outperofrm, Target cut to 1235 from 1265 Citi on IGL Maintain Buy, Target cut to 480 from 490 Jefferies on IGL Maintain Buy, Target raised to 475 from 450 #Brokeragereport #q3results
#CNBCTV18Market | MS gives an overweight rating on Cipla, says co continues to enrich its us pipeline with inhalers and peptides. Good visibility of 3-4 complex launches every yr for next 3 yrs
-